This site is intended for health professionals only

Published on 26 October 2012

Share this story:
Twitter
LinkedIn

Nicox financial results

teaser

Following the completion of the worldwide in-licensing agreement in June 2012 with Rapid Pathogen Screening, Inc (RPS®) for several innovative diagnostic tests, including AdenoPlus(TM), Nicox has been building up its commercial organisation in the US and in Europe.
In August 2012, Nicox strengthened its US business operations with the appointment of Jason Menzo as Director of Marketing, Mark Puwal as National Director of Sales and Jason Werner as Director of Commercial Development & Strategic Alliances for Nicox Inc., its US subsidiary. These followed the appointment of Jerry St. Peter as Executive Vice President and General Manager of Nicox Inc. in March 2012 and Philippe Masquida as Executive Vice-President, Managing Director of European Operations in April 2012.
Click here to read the rest of the report:
hugin.info/143509/R/1652076/533153.pdf


Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn